Company continues to grow its global retail footprint by partnering with the world’s largest e-commerce site
VANCOUVER, BC, February 28, 2022 /CNW/ – HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (ESF: 5NP) (the “Company” or “HAVN Life”), a biotechnology company that develops natural health products and innovative therapies to support brain health and cognitive function, is pleased to announce that its portfolio of health products Naturals is now available on Amazon.com. E-commerce giant offers HAVN Life’s full line of natural health products launched last Juneand ships to over 100 countries worldwide.
“Over the past year, HAVN Life has worked tirelessly to build a strong foundation for our retail division by securing distribution partnerships and ensuring our line of natural health products is available through the intermediary of the best possible e-commerce partners,” said the CEO of HAVN Life. Tim Moore. “Today, we are thrilled to announce that the HAVN Life suite of products will be sold through Amazon.com – the world’s largest e-commerce site. With our growing retail presence, HAVN Life is consolidating its position as an international supplier of natural herbal health supplements, reinforcing its role as a supply chain leader in functional mushroom natural health products,” he adds.
The full range includes Rhodiola Relief, mind mushroom, Chaga immunity, Reishi Refill, Bacopa Brain, Lion’s mane and Cordyceps perform and is now available on Amazon.com, Amazon.ca and Well.caas well as through their HAVN Life e-commerce site, yourhavnlife.com, which ships products to US and Canadian customers. Products can also be purchased at Horizon Grocery + Wellness, Choices Market and Nesters Market stores at British Columbia, Canadaas well as at independent specialty retailers across Canada.
HAVN Life’s natural health products are expected to be introduced in Australia, New Zealand and the Chinese market in 2022 through the Company Distribution Partner, Woke Pharmaceuticals. the sydneyThe New York-based company has distribution channels through Australian retailers, including major supermarkets and other retail outlets, as well as through various e-commerce portals such as Australia and New Zealand Amazon sites.
HAVN Life formulations are non-GMO, vegan, bioavailable and naturally derived from functional fungi and other botanicals and created with human optimization in mind. The line of natural health products has been carefully formulated with adaptogens and antioxidants to support overall brain health, with natural compounds proven to support memory, focus, energy and overall cognitive function .
On behalf of the Board of Directors
Chief Executive Officer
About HAVN Life Sciences Inc.
HAVN Life Sciences is a biotechnology company that pursues the standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products and innovative therapies to support brain health and cognitive function.
Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of GMP naturally occurring psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, HAVN Life offers a full line of high-quality mushroom and herbal extracts that help boost immune function, reduce inflammation, and support a healthy lifestyle.
Forward-Looking Information: This press release contains “forward-looking information” within the meaning of applicable securities laws regarding statements regarding the Company’s business, products and future business, including the planned introduction of Natural Health Society on the Australian, New Zealand and Chinese markets in 2022. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. These forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by such statements depending, among other things, on the risks that the introduction of the products of the Company’s natural health products in the Australian market, New Zealand and Chinese markets in 2022 will not be completed as planned, or at all, and the risks that the Company’s products and plan will differ from those disclosed in this press release and the Company may not be able to complete its business plans as planned. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking information contained in this press release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. The statements contained in this press release are made as of the date of this press release.
The CSE has not reviewed, approved or disapproved of the contents of this press release.
SOURCEHAVN Life Sciences Inc.
For more information: Investor Relations: [email protected] 604 359 0060; Media: [email protected] 647 896 8078